Lv1
60 积分 2025-03-17 加入
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
1个月前
已完结
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
1个月前
已完结
Questions and answers on PARP inhibitor use in somatic BRCA–mutated breast cancers
1个月前
已完结
Elucidating cooperative genetic events in DCIS progression in mutant p53 –driven breast cancer
2个月前
已关闭
Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
3个月前
已完结
Replacement as an aging intervention
4个月前
已完结
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity
5个月前
已完结
Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells
6个月前
已完结
Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells
6个月前
已完结
Germline CDH1 Variants and Lifetime Cancer Risk
6个月前
已完结
皖公网安备34019202002308
